These studies suggest that DSIP appears to improve or at least maintain normal and disrupted sleep in humans
Wu D, He H, Chen J, Yao S, Xie H, Jiang W, et al
Gut and systemic GLP-1 resistance have been previously described in HFD-fed mice, associated with dysglycemia, insulin resistance, increased food intake, and impaired gastric emptying, and attributed to an acquired impairment of the gut-brain axis secondary to intestinal dysbiosis (34)
Empagliflozin operates through a novel mechanism of action distinct from traditional diabetes medications
and death from any cause
People familiar with semaglutide withdrawal symptoms know that stopping and starting GLP-1 approaches carries its own challenges regardless of whether the approach is pharmaceutical or probiotic